AKT1 and neoplasm: In detail, both tumour TMB and blood TMB were significantly higher in the AKT pathway altered group (tTMB: 15.7% vs. 8.3%, p < 0.001, bTMB: 15.7% vs. 4.3%, p < 0.001, respectively).